190 Results

People

  1. Saltz
    Saltz
  2. Kelsen
    Kelsen
  3. Bajorin
    Bajorin
  4. O'Reilly
    O'Reilly
  5. Abrey
    Abrey
  6. Marks
    Marks
  7. Aghajanian
    Aghajanian
  8. Ilson
    Ilson
  9. De Angelis
    De Angelis
  10. Kelly
    Kelly

Groups

  1. Department of Medicine (143)
  2. Solid Tumor Oncology Division (115)
  3. Gastrointestinal Oncology Service (39)
  4. Epidemiology and Biostatistics (31)
  5. Biostatistics Service (29)
  6. Center for Pancreatic Cancer Research (29)
  7. Hematologic Malignancies, Division of (29)
  8. Survivorship Research (27)
  9. Genitourinary Oncology Service (25)
  10. Surgery (25)
  1. "dehydration"
Formats
  1. Journal Article (185)
  2. Review (2)
  3. Book Section (1)
  4. Conference Paper (1)
  5. Editorial (1)
Groups
  1. Department of Medicine (143)
  2. Solid Tumor Oncology Division (115)
  3. Gastrointestinal Oncology Service (39)
  4. Epidemiology and Biostatistics (31)
  5. Biostatistics Service (29)
  6. Center for Pancreatic Cancer Research (29)

More Groups

People
  1. Leonard Saltz (12)
  2. David Kelsen (10)
  3. Dean Bajorin (9)
  4. Eileen O'Reilly (9)
  5. Lauren Abrey (8)
  6. Paul Marks (8)

More People

Years
  1. 2025 (1)
  2. 2024 (11)
  3. 2023 (7)
  4. 2022 (2)
  5. 2021 (6)
  6. 2020 (11)

More Years

Publications
  1. Cancer (17)
  2. Journal of Clinical Oncology (16)
  3. Lancet Oncology (14)
  4. Gynecologic Oncology (10)
  5. Investigational New Drugs (10)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier Inc. (31)
  2. Springer (21)
  3. Wiley Blackwell (20)
  4. American Society of Clinical Oncology (16)
  5. Elsevier Science, Inc. (16)
  6. Oxford University Press (16)

More Publishers

Results (190)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation
    Journal Article

    Straus, D. J.; Hamlin, P. A.; Matasar, M. J.; Lia Palomba, M.; Drullinsky, P. R.; Zelenetz, A. D.; Gerecitano, J. F.; Noy, A.; Hamilton, A. M.; Elstrom, R.; more...
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Prevention of post-operative delirium in older patients with cancer undergoing surgery
    Journal Article

    Korc-Grodzicki, B.; Root, J. C.; Alici, Y.
    Journal of Geriatric Oncology (2015)

    Fulltext@MSK | Save
  • Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
    Journal Article

    Kaley, T. J.; Wen, P.; Schiff, D.; Ligon, K.; Haidar, S.; Karimi, S.; Lassman, A. B.; Nolan, C. P.; De Angelis, L. M.; Gavrilovic, I.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer
    Journal Article

    Saura, C.; Garcia-Saenz, J. A.; Xu, B.; Harb, W.; Moroose, R.; Pluard, T.; CorteĢs, J.; Kiger, C.; Germa, C.; Wang, K.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.; Barrios, C. H.; Kim, T. M.; Falcon, S.; Cosgriff, T.; Harker, W. G.; Srimuninnimit, V.; Pittman, K.; Sabbatini, R.; Rha, S. Y.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study
    Journal Article

    Pappo, A. S.; Vassal, G.; Crowley, J. J.; Bolejack, V.; Hogendoorn, P. C. W.; Chugh, R.; Ladanyi, M.; Grippo, J. F.; Dall, G.; Staddon, A. P.; more...
    Cancer (2014)

    Fulltext@MSK | Save
  • Trimodality therapy for superior sulcus non-small cell lung cancer: Southwest Oncology Group-Intergroup Trial s0220
    Journal Article

    Kernstine, K. H.; Moon, J.; Kraut, M. J.; Pisters, K. M. W.; Sonett, J. R.; Rusch, V. W.; Thomas, C. R. Jr; Waddell, T. K.; Jett, J. R.; Lyss, A. P.; more...
    Annals of Thoracic Surgery (2014)

    Fulltext@MSK | Save
  • Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma
    Journal Article

    Hutson, T. E.; Bukowski, R. M.; Rini, B. I.; Gore, M. E.; Larkin, J. M.; Figlin, R. A.; Barrios, C. H.; Escudier, B.; Lin, X.; Fly, K.; more...
    British Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Neoadjuvant radiation therapy prior to total mesorectal excision for rectal cancer is not associated with postoperative complications using current techniques
    Journal Article

    Milgrom, S. A.; Goodman, K. A.; Nash, G. M.; Paty, P. B.; Guillem, J. G.; Temple, L. K.; Weiser, M. R.; Garcia-Aguilar, J.
    Annals of Surgical Oncology (2014)

    Fulltext@MSK | Save
  • Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial
    Journal Article

    Kwon, E. D.; Drake, C. G.; Scher, H. I.; Fizazi, K.; Bossi, A.; Van Den Eertwegh, A. J. M.; Krainer, M.; Houede, N.; Santos, R.; Mahammedi, H.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save